Infusion cell freezing medium and application thereof

The invention provides an infusion cell cryopreservation solution. The infusion cell cryopreservation solution comprises the following components in percentage by volume: 10% of glycerol; 20% of a human serum albumin injection; and the balance of hydroxyethyl starch 40 sodium chloride injection. Whe...

Full description

Saved in:
Bibliographic Details
Main Authors TAN WENSONG, HUANG HUIMIN, CAI HAIBO, SHI XIAODI
Format Patent
LanguageChinese
English
Published 01.04.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention provides an infusion cell cryopreservation solution. The infusion cell cryopreservation solution comprises the following components in percentage by volume: 10% of glycerol; 20% of a human serum albumin injection; and the balance of hydroxyethyl starch 40 sodium chloride injection. Wherein the human serum albumin injection contains human serum albumin with the mass ratio of 20%; the hydroxyethyl starch 40 sodium chloride injection comprises 60g/L of hydroxyethyl starch 40 and 9g/L of sodium chloride. The cell freezing medium capable of being infused does not contain dimethyl sulfoxide, clinical adverse reactions caused by dimethyl sulfoxide in a traditional cell freezing medium are avoided, and efficient, safe and stable cell freezing is achieved; in addition, the cell cryopreservation liquid capable of being infused can be used for clinical-grade cryopreservation of CAR-NK cells and can be directly infused after resuscitation. 本申请提供一种可输注细胞冻存液,其按体积百分比包含:甘油10%;人血白蛋白注射液20%;以及余量为羟乙基淀粉40氯化钠注射液;其中,所述
Bibliography:Application Number: CN202210026083